Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
Qatar
File

Qatar: genome regulation atlas

This dossier follows the genomic atlas presented by Sidra Medicine, its data and validation of medical applications.

Last updated : 1 key moments
Stethoscope on a white background.
Generic medical illustration from 2014; it does not depict the study or campaign. Sprinno, CC0. — Sprinno / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — 28 février 2014, sans modification.

Where things stand

Sidra Medicine presented an atlas linking DNA variation to gene activity in blood on 4 November 2026. The institution says the study, based on nearly 2,000 Qatar Biobank participants, is published in Nature Genetics.

Reported information

Sidra Medicine announces genomic atlas based on nearly 2,000 Qatar participants

Sidra Medicine presented an atlas linking DNA variation to gene activity in blood on 4 November 2026. The institution says the study, based on nearly 2,000 Qatar Biobank participants, is published in Nature Genetics.

Stethoscope on a white background.
Generic medical illustration from 2014; it does not depict the study or campaign. Sprinno, CC0. — Sprinno / Wikimedia Commons — CC0 1.0 https://creativecommons.org/publicdomain/zero/1.0/ — 28 février 2014, sans modification.

According to Sidra, researchers combined genome sequencing, blood gene expression and clinical information. The aim is to better interpret genetic variation in Middle Eastern populations underrepresented in global research.

This is a research resource. Proposed benefits for risk assessment, biomarkers or future treatments are not demonstrated clinical outcomes in patients. The full study could not be accessed during this check, so the findings are attributed to the institution.

Sources 2